Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: therapeutic and endocrine effects in postmenopausal advanced breast cancer patients.
Gasparini G, Canobbio L, Galligioni E, Fassio T, Brema F, Crivellari D, Villalta D, Di Fronzo G, Talamini R, Monfardini S. Gasparini G, et al. Among authors: brema f. Eur J Cancer Clin Oncol. 1987 Oct;23(10):1451-9. doi: 10.1016/0277-5379(87)90086-1. Eur J Cancer Clin Oncol. 1987. PMID: 2960532
Phase-II study of Navelbine in advanced breast cancer.
Canobbio L, Boccardo F, Pastorino G, Brema F, Martini C, Resasco M, Santi L. Canobbio L, et al. Among authors: brema f. Semin Oncol. 1989 Apr;16(2 Suppl 4):33-6. Semin Oncol. 1989. PMID: 2711204 No abstract available.
Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trial.
Murialdo R, Bertolotti F, Pastorino G, Mencoboni M, Bergaglio M, Folco U, Cinzia N, Vaira F, Simoni C, Canobbio L, Parodi M, Brema F, Ballestrero A. Murialdo R, et al. Among authors: brema f. Cancer Chemother Pharmacol. 2011 Oct;68(4):1009-16. doi: 10.1007/s00280-011-1570-7. Epub 2011 Feb 16. Cancer Chemother Pharmacol. 2011. PMID: 21327683 Clinical Trial.
Paclitaxel plus ifosfamide in advanced ovarian cancer: a multicenter phase II study.
Miglietta L, Amoroso D, Bruzzone M, Granetto C, Catsafados E, Mammoliti S, Guarneri D, Pedulla F, Foglia G, Ragni N, Martini MC, Brema F, Addamo G, Moraglio L, Pastorino G, Boccardo F. Miglietta L, et al. Among authors: brema f. Oncology. 1997 Mar-Apr;54(2):102-7. doi: 10.1159/000227671. Oncology. 1997. PMID: 9075779 Clinical Trial.
42 results